Drug-eluting stents for diabetes mellitus: A rush to judgment?
- 15 February 2005
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (4) , 479-483
- https://doi.org/10.1016/j.jacc.2004.10.060
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Impact of Sirolimus-Eluting Stents on Outcome in Diabetic PatientsCirculation, 2004
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Optimization of glycemic control and restenosis prevention in diabetic patients undergoing percutaneous coronary interventions**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.Journal of the American College of Cardiology, 2004
- Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary interventionJournal of the American College of Cardiology, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Clinical restenosis after coronary stenting: perspectives from multicenter clinical trialsPublished by Elsevier ,2002
- Coronary stenting in diabetics: Immediate and mid-term clinical outcomeCatheterization and Cardiovascular Interventions, 1999
- The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantationJournal of the American College of Cardiology, 1998
- Incidence and Prognosis of Unrecognized Myocardial InfarctionNew England Journal of Medicine, 1984